Literature DB >> 24413330

Orthotopic heart transplantation for congenital heart defects: anomalies of the systemic venous return.

Olivier Raisky1, Daniel Tamisier, Pascal R Vouhé.   

Abstract

Anomalies of the systemic venous return are frequently associated with other congenital heart defects. Some anomalies do not complicate really orthotopic heart transplantation (such as azygos continuation of the inferior vena cava). Other anomalies raise more difficulties; the most frequent one is persistent left superior vena cava draining into either the coronary sinus or the left atrium. Sometimes, the left superior vena cava can be ligated without untoward effect. In most cases, the left superior vena cava must be anastomosed to the right atrial compartment, preferably using extracardiac procedures. Most problems can be solved by harvesting extra lengths of donor superior vena cava and innominate vein. In rare patients, associated anomalies of the pulmonary venous return may require additional partitioning of the atria. The early risk of heart transplantation is probably not increased by the presence of such anomalies.

Entities:  

Year:  2006        PMID: 24413330     DOI: 10.1510/mmcts.2005.001578

Source DB:  PubMed          Journal:  Multimed Man Cardiothorac Surg        ISSN: 1813-9175


  3 in total

1.  Heart transplantation in a patient with persistent left superior vena cava.

Authors:  Jae-Hong Lee; Eun-Ah Park; Whal Lee; Hyun-Jai Cho; Ki-Bong Kim; Ho Young Hwang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-12-05

2.  Persistent Left Superior Vena Cava: Implications of Surgical Management.

Authors:  Robin Boyer; Ramanjeet Sidhu; Aslan Ghandforoush; Theingi Win; Arash Heidari
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

3.  Orthotopic heart transplantation with reconstruction of persistent left superior vena cava.

Authors:  Kazuma Handa; Hiroki Hata; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Daisuke Yoshioka; Yoshiki Sawa
Journal:  Surg Case Rep       Date:  2020-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.